NEOS THERAPEUTICS INC - COM (NEOS)

CUSIP: 64052L106

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM
Total 13F shares
21,669,868
Share change
+1,168,761
Total reported value
$32,712,135
Price per share
$1.51
Number of holders
49
Value change
+$1,767,703
Number of buys
16
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 64052L106?
CUSIP 64052L106 identifies NEOS - NEOS THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOS THERAPEUTICS INC - COM (NEOS) as of Q4 2019

As of 31 Dec 2019, NEOS THERAPEUTICS INC - COM (NEOS) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,669,868 shares. The largest 10 holders included Stonepine Capital Management, LLC, Nantahala Capital Management, LLC, SPHERA FUNDS MANAGEMENT LTD., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Russell Investments Group, Ltd., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). This page lists 49 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.